Clinical and Radiological Outcomes of Medacta Shoulder System FR (NCT05926622) | Clinical Trial Compass
RecruitingNot Applicable
Clinical and Radiological Outcomes of Medacta Shoulder System FR
France200 participantsStarted 2022-03-15
Plain-language summary
This is a post-marketing surveillance on Medacta Shoulder System
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients older than 18 years
* Patient with one of the following diagnosis:
Primary osteoarthritis Secondary osteoarthritis Cuff tear arthropathy; insufficient rotator cuff Acute fracture (\<21d) Rheumatoid or inflammatory arthritis Avascular necrosis Other posttraumatic condition Revision of shoulder arthroplasty
Exclusion Criteria:
* Patients with malignant diseases (at the time of surgery)
* Patients with proven or suspect infections (at the time of surgery)
* Patients with functional deficits other than dysfunction of the shoulder (at the time of surgery)
* Patients with known incompatibility or allergy to products materials (at the time of surgery)